Statistics

Total Visits

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial57

Select a period of time:

Number of views in the range

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial31

Views

Views
January 20252
February 20257
March 202515
April 20254
May 20250
June 20253
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States12
Germany1
Spain1
United Kingdom1
Hong Kong1
 

Top cities views

Views
Council Bluffs1
Hong Kong1